Related Experiment Video
Updated: Mar 14, 2026

Quantitative Multispectral Analysis Following Fluorescent Tissue Transplant for Visualization of Cell Origins, Types, and Interactions
Published on: September 22, 2013
Multi-Phenotypic subtyping of circulating tumor cells using sequential fluorescent quenching and restaining
Daniel L Adams1, R Katherine Alpaugh2, Susan Tsai3
1Creatv MicroTech, Inc., 1 Deer Park Dr. Monmouth Junction, NJ 08850, USA.
Researchers developed a cost-effective method to analyze more biomarkers on circulating tumor cells (CTCs) from blood biopsies. This technique enhances the clinical utility of blood-based biopsies for cancer subtyping and patient stratification.
Area of Science:
- Biomedical Science
- Cancer Research
- Molecular Diagnostics
Background:
- Tissue biopsies using formalin-fixed paraffin-embedded blocks allow extensive proteomic and genomic subtyping of cancer specimens.
- Blood-based biopsies (BBBs) currently offer limited clinical utility, primarily for enumerating circulating tumor cells (CTCs) due to restrictions on the number of detectable fluorescent markers.
Purpose of the Study:
- To develop a simple, inexpensive method to increase the number of subtyping biomarkers detectable on individual CTCs.
- To enhance the clinical utility of BBBs by enabling in-depth interrogation of CTCs.
Main Methods:
- A novel technique for quenching specific fluorophores on stained CTCs.
- Sequential restaining of CTCs with additional biomarkers after quenching.
- Proof-of-principle analysis using CTC, immunosuppression, and stem cell panels.
Main Results:
- Demonstrated a method to sequentially subtype individual fluorescently stained patient CTCs.
- Successfully applied CTC, immunosuppression, and stem cell panels for multi-marker analysis.
- Showcased the ability to analyze multiple clinically applicable immunomarkers from a single CTC sample.
Conclusions:
- The developed method provides a simple and universal technique for analyzing multiple immunomarkers from BBBs.
- This approach significantly expands the potential of CTC analysis for cancer subtyping and clinical decision-making.
- Enhanced CTC subtyping via sequential staining promises to revolutionize the diagnostic and prognostic capabilities of blood-based biopsies.
More Related Videos
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
09:45Microfluidics-based High-throughput Circulating Tumor Cell Sorting and Single-cell Sequencing Technology
Published on: November 14, 2025